132 related articles for article (PubMed ID: 24330666)
1. An International Collaborative Study to establish the WHO 2nd International Standard for High Molecular Weight Urokinase: communication from SSC of the ISTH.
Longstaff C; Thelwell C; Rigsby P;
J Thromb Haemost; 2014; 12(3):415-7. PubMed ID: 24330666
[No Abstract] [Full Text] [Related]
2. An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140): communication from the SSC of the ISTH.
Thelwell C; Rigsby P; Locke M; Bevan S; Longstaff C
J Thromb Haemost; 2018 May; 16(5):1003-1006. PubMed ID: 29607604
[No Abstract] [Full Text] [Related]
3. An International Collaborative Study to establish the World Health Organization 4th International Standard for Plasmin (13/206): communication from the SSC of the ISTH.
Thelwell C; Longstaff C; Rigsby P;
J Thromb Haemost; 2016 Jan; 14(1):215-8. PubMed ID: 27028402
[No Abstract] [Full Text] [Related]
4. [Inactivation and stabilization of urokinase fibrinolytic activity in vitro].
Aĭsina RB; Mukhametova LI; Sazonova IIu; Varfolomeev SD
Bioorg Khim; 1998 Jul; 24(7):544-8. PubMed ID: 9749317
[TBL] [Abstract][Full Text] [Related]
5. An international collaborative study to establish the World Health Organization 2nd International Standard for Factor VII Concentrate: communication from the SSC of the ISTH.
Thelwell C; Rigsby P; Bevan S; Beeharry M;
J Thromb Haemost; 2014 Oct; 12(10):1750-3. PubMed ID: 25056848
[No Abstract] [Full Text] [Related]
6. [High Molecular Weight Urokinase Reference Standard (Control 901) of National Institute of Health Sciences].
Okada S; Yomota C; Murai M; Tanimoto T; Kimura T
Eisei Shikenjo Hokoku; 1993; (111):133-6. PubMed ID: 7920555
[TBL] [Abstract][Full Text] [Related]
7. International collaborative study on the assay of commerically available high and low molecular weight urokinases.
Gaffney PJ; Tydeman MS; Kirkwood TB; Aronson D; Murano G
Thromb Haemost; 1981 Feb; 45(1):34-7. PubMed ID: 7018003
[TBL] [Abstract][Full Text] [Related]
8. A collaborative study to establish a standard for high molecular weight urinary-type plasminogen activator (HMW/u-PA).
Gaffney PJ; Heath AB
Thromb Haemost; 1990 Nov; 64(3):398-401. PubMed ID: 2128969
[TBL] [Abstract][Full Text] [Related]
9. International collaborative study to establish the World Health Organization 2nd International Standard for Fibrinogen Concentrate (09/242): communication from the SSC of the ISTH.
Raut S; Hamill M; Heath AB;
J Thromb Haemost; 2016 Oct; 14(10):2068-2072. PubMed ID: 27660008
[No Abstract] [Full Text] [Related]
10. Calibration of the WHO 1st international standard and SSC/ISTH secondary coagulation standard for tissue plasminogen activator antigen in plasma.
Longstaff C; Rigsby P; Whitton C;
J Thromb Haemost; 2010 Aug; 8(8):1855-7. PubMed ID: 20546122
[No Abstract] [Full Text] [Related]
11. Amediplase. Menarini.
Doggrell SA
Curr Opin Investig Drugs; 2004 Mar; 5(3):344-7. PubMed ID: 15083603
[TBL] [Abstract][Full Text] [Related]
12. Purification of high molecular weight urokinase from human urine and comparative study of two active forms of urokinase.
Shibatani T; Kakimoto T; Chibata I
Thromb Haemost; 1983 Apr; 49(2):91-5. PubMed ID: 6346574
[TBL] [Abstract][Full Text] [Related]
13. [Isolation of a third human urokinase (S0 type)].
Doleschel W
Wien Klin Wochenschr; 1975 Apr; 87(8):282-4. PubMed ID: 1220276
[TBL] [Abstract][Full Text] [Related]
14. Experimentally targeted thrombolytic therapy. Application of modified thrombin conjugated with urokinase.
Maksimenko AV; Petrov AD; Tischenko EG; Smirnov MD
Ann N Y Acad Sci; 1995 Mar; 750():496-501. PubMed ID: 7785879
[No Abstract] [Full Text] [Related]
15. Physicochemical properties of highly purified kidney cultured plasminogen activator (single chain urokinase).
Sumi H; Kosugi T; Matsuo O; Mihara H
Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):119-28. PubMed ID: 7051725
[No Abstract] [Full Text] [Related]
16. Establishment of replacement batches for heparin low-molecular-mass for calibration CRS, and the International Standard Low Molecular Weight Heparin for Calibration.
Mulloy B; Heath A; Behr-Gross ME
Pharmeuropa Bio; 2007 Dec; 2007(1):29-48. PubMed ID: 18413136
[TBL] [Abstract][Full Text] [Related]
17. Thrombolytic agents.
Collen D; Lijnen HR
Thromb Haemost; 2005 Apr; 93(4):627-30. PubMed ID: 15841305
[TBL] [Abstract][Full Text] [Related]
18. [Development of the high effective thrombolytic agents with molecular biological technique].
Wu HZ; Li JZ
Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):11-3. PubMed ID: 8404311
[No Abstract] [Full Text] [Related]
19. Urokinase activity after freezing: implications for thrombolysis in intraventricular hemorrhage.
Rhoney DH; Coplin WM; Zaran FK; Brish LK; Weingarten CM
Am J Health Syst Pharm; 1999 Oct; 56(20):2047-51. PubMed ID: 10541031
[TBL] [Abstract][Full Text] [Related]
20. The ideal fibrinolytic: can drug design improve clinical results?
Van de Werf FJ
Eur Heart J; 1999 Oct; 20(20):1452-8. PubMed ID: 10493843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
